A Case of Rhabdomyolysis Induced by Lipid Lowering Agent

지질강하제에 의한 횡문근 융해증 1예

  • Koh, Eun-Mi (Department of Internal Medicine, College of Medicine, Kyung Hee University) ;
  • Lee, Tae-Won (Department of Internal Medicine, College of Medicine, Kyung Hee University) ;
  • Ihm, Chun-Gyoo (Department of Internal Medicine, College of Medicine, Kyung Hee University) ;
  • Kim, Kwang-Won (Department of Internal Medicine, College of Medicine, Kyung Hee University) ;
  • Kim, Myung-Jae (Department of Internal Medicine, College of Medicine, Kyung Hee University) ;
  • Choi, Young-Kil (Department of Internal Medicine, College of Medicine, Kyung Hee University)
  • 고은미 (경희대학교 의과대학 내과학교실) ;
  • 이태원 (경희대학교 의과대학 내과학교실) ;
  • 임천규 (경희대학교 의과대학 내과학교실) ;
  • 김광원 (경희대학교 의과대학 내과학교실) ;
  • 김명재 (경희대학교 의과대학 내과학교실) ;
  • 최영길 (경희대학교 의과대학 내과학교실)
  • Published : 1990.04.25

Abstract

Bezafibrate is a lipid?lowering agent and one of the fibric acid derivatives. It is relatively safe and well tolerated and adverse reactions to bezafibrate have largely been restricted to gastrointestinal distrubances. But a few cases of rhabdomyolysis after bezafibrate administration have been reported and recently we experienced bezafibrate-induced rhabdomyolysis in patients with chronic renal failure. So we report this case with the bone scan finding and the literature review We believe that this is the first case report of bezafibrate-induced rhabdomyolysis in Korea.

Keywords